Key Insights
1. Funding Cuts Are Creating Systemic Risk
An estimated $9B reduction in global health funding is weakening disease programs and disrupting the infrastructure that supports clinical trials.
2. Primary Healthcare Clinics Are Critical Infrastructure
PHCs are not just care centers—they are essential nodes for clinical trial supply, handling storage, distribution, and patient-level delivery of investigational products.
3. Supply Chains Are Increasingly Fragile
Breakdowns in cold chain logistics, inventory tracking, and resupply planning are creating operational risks that can delay or derail trials.
4. Restarting Systems Is Complex and Slow
Reopening clinics requires rebuilding infrastructure, retraining staff, and restoring supply networks—far beyond simply turning services back on.
5. Community Engagement Drives Trial Stability
Patient recruitment and retention directly impact supply forecasting and inventory management, making local trust a key operational factor.
6. Sustainability Is the Biggest Challenge
Long-term success depends on consistent funding, trained personnel, and reliable logistics—not just initial investment.
7. Strong PHCs Enable Better Research Outcomes
Well-supported clinics improve both healthcare delivery and clinical trial performance, making them a high-impact investment area.